← Back to Search

Behavioural Intervention

Intervention for Cardiovascular Disease

N/A
Waitlist Available
Led By Eleanor O Caplan, PharmD, PhD
Research Sponsored by Humana Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights

Study Summary

This study is evaluating whether a set of educational materials can improve the use of medications for people with type 2 diabetes.

Eligible Conditions
  • Cardiovascular Disease
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Pharmaceutical Preparations
Pharmaceutical Preparations
Percentage of individuals who initiate guideline-based SGLT2i or GLP-1 RA medications with cardiovascular benefit, excluding combination products, based on administrative claims data
+1 more

Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Patients and primary care providers randomly selected and assigned to the control arm will not receive any of the educational outreach communications.
Group II: InterventionActive Control1 Intervention
The educational outreach intervention will entail a multi-faced strategy to provide patients resources to learn more about reducing their risk for heart disease and supporting providers in the care of their patients by sharing recent guideline-recommended treatments for these high-risk individuals.

Find a Location

Who is running the clinical trial?

Humana Inc.Lead Sponsor
7 Previous Clinical Trials
676,748 Total Patients Enrolled
Boehringer IngelheimIndustry Sponsor
2,505 Previous Clinical Trials
11,336,095 Total Patients Enrolled
Humana Healthcare Research, Inc.UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes
Alexjandro Daviano 2021. "Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04862858.
~1145 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top